Cargando…
Clinical Feasibility and Safety of Scleral Collagen Cross-Linking by Riboflavin and Ultraviolet A in Pathological Myopia Blindness: A Pilot Study
INTRODUCTION: To investigate the feasibility and safety of scleral ultraviolet A (UVA) cross-linking (scleral CXL) on pathologically blindness. METHODS: This was a prospective, observational clinical study. Five patients with monocular blindness due to pathological myopic maculopathy were enrolled....
Autores principales: | Li, Yu, Qi, Yue, Sun, Mingshen, Zhai, Changbin, Wei, Wenbin, Zhang, Fengju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768409/ https://www.ncbi.nlm.nih.gov/pubmed/36542255 http://dx.doi.org/10.1007/s40123-022-00633-5 |
Ejemplares similares
-
Study of retina and choroid biological parameters of rhesus monkeys eyes on scleral collagen cross-linking by riboflavin and ultraviolet A
por: Sun, Mingshen, et al.
Publicado: (2018) -
Effects of riboflavin/ultraviolet-A scleral collagen cross-linking on regional scleral thickness and expression of MMP-2 and MT1-MMP in myopic guinea pigs
por: Lv, Xiaotong, et al.
Publicado: (2023) -
Shaping Eyeballs by Scleral Collagen Cross-Linking: A Hypothesis for Myopia Treatment
por: Wang, Mengmeng, et al.
Publicado: (2021) -
Scleral wound healing with cross-link technique using riboflavin and ultraviolet A on rabbit eyes
por: Damasceno, Nadyr A, et al.
Publicado: (2017) -
Comment on: Corneal collagen cross-linking with riboflavin and ultraviolet: A light for keratoconus
por: Parthasarathy, Anand
Publicado: (2010)